Cancer testis antigen and immunotherapy

被引：45
|
作者：
Krishnadas, Deepa Kolaseri [1 ]
Bai, Fanqi [1 ]
Lucas, Kenneth G. [1 ]
机构：
[1] Univ Louisville, Dept Pediat, Div Hematol Oncol, Louisville, KY 40292 USA
来源：
IMMUNOTARGETS AND THERAPY | 2013年 / 2卷
关键词：
cancer testis antigens; immunotherapy; vaccine;
D O I：
10.2147/ITT.S35570
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The identification of cancer testis (CT) antigens has been an important advance in determining potential targets for cancer immunotherapy. Multiple previous studies have shown that CT antigen vaccines, using both peptides and dendritic cell vaccines, can elicit clinical and immunologic responses in several different tumors. This review details the expression of melanoma antigen family A, 1 (MAGE-A1), melanoma antigen family A, 3 (MAGE-A3), and New York esophageal squamous cell carcinoma-1 (NY-ESO-1) in various malignancies, and presents our current understanding of CT antigen based immunotherapy.
引用
收藏
页码：11 / 19
页数：9
相关论文
共 50 条
  • [1] A novel era of cancer/testis antigen in cancer immunotherapy
    Meng, Xiaoyan
    Sun, Xueqing
    Liu, Zhonglong
    He, Yue
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 98
  • [2] The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer
    Xu, Yichi
    Zou, Ruanmin
    Wang, Jing
    Wang, Zhi-wei
    Zhu, Xueqiong
    CELL PROLIFERATION, 2020, 53 (03)
  • [3] The expression of cancer-testis antigen in ovarian cancer and the development of immunotherapy
    Zhao, Jianhang
    Xu, Zhaoxu
    Liu, Yan
    Wang, Xiaobin
    Liu, Xinli
    Gao, Yanan
    Jin, Ying
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (02): : 681 - 694
  • [4] Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects
    Wei, Xiao
    Chen, Fangjun
    Xin, Kai
    Wang, Qin
    Yu, Lixia
    Liu, Baorui
    Liu, Qin
    TRANSLATIONAL ONCOLOGY, 2019, 12 (05): : 733 - 738
  • [5] Cancer Testis Antigen, Ropporin, Is a Potential Target for Multiple Myeloma Immunotherapy
    Chiriva-Internati, Maurizio
    Mirandola, Leonardo
    Yu, Yuefei
    Jenkins, Marjorie R.
    Gornati, Rosalba
    Bernardini, Giovanni
    Gioia, Magda
    Chiaramonte, Raffaella
    Cannon, Martin J.
    Kast, W. Martin
    Cobos, Everardo
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (06) : 490 - 499
  • [6] Cancer immunotherapy: Identifying cancer testis antigen peptides to enhance antitumor response.
    Haque, Syed Mahdee
    Salman, Abdul-Rahman
    Abdeen, Hamdi
    Krieger, Elizabeth
    Manjili, Masoud
    Qayyum, Rehan
    Boikos, Sosipatros Alexandros
    Toor, Amir A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] CANCER TESTIS ANTIGEN BURDEN: A NOVEL PREDICTIVE BIOMARKER FOR IMMUNOTHERAPY IN SOLID TUMORS
    Pabla, Sarabjot
    Seager, R. J.
    Lee, Yong Hee
    Van Roey, Erik
    Gao, Shuang
    Giamo, Vincent
    Burgher, Blake
    DePietro, Paul
    Nesline, Mary
    Glenn, Sean
    Zhang, Shengle
    Conroy, Jeffrey
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A89 - A89
  • [8] Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy
    Bodey, B
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (06) : 577 - 584
  • [9] Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer
    Chiriva-Internati, Maurizio
    Yu, Yuefei
    Mirandola, Leonardo
    D'Cunha, Nicholas
    Hardwicke, Fred
    Cannon, Martin J.
    Cobos, Everardo
    Kast, W. Martin
    PROSTATE, 2012, 72 (01): : 12 - 23
  • [10] TCR Against Cancer Testis Antigen MAGE-A3 for Targeted Adoptive Immunotherapy of Cancer
    Chinnasamy, Nachimuthu
    Waigo, Jennifer A.
    Yu, Zhiya
    Frankel, Timothy L.
    Riley, John P.
    Paikhuist, Maria R.
    Restifo, Nicholas P.
    Robbins, Paul F.
    Rosenberg, Steven A.
    Morgan, Richard A.
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 941 - 942
12345